R-Zero Website The future of R-Zero COVID-19 exposed how vulnerable we are to infectious diseases. But the challenge is bigger than Coronavirus alone. When it comes to infection prevention, we need a new normal. Norovirus impacts 19 to 21 million Americans every year, and costs $2 billion annually. Influenza impacts 30 to 40 million Americans every year and costs $10.4 billion annually. E. coli impacts 265 thousand Americans every year. At R-Zero, we’ve developed a suite of solutions designed to greatly reduce the staggering damage each one of those viruses causes to our health and the health of our economy. We’re establishing a new standard for public health. One to address and overcome the challenges we face today and in the future. We are a biosafety company dedicated to making safer everyday spaces and common places. We thoughtfully design the most effective technologies and protocols to reduce our world of deadly pathogens—today and forever.
